Recent Press Releases

UNMC Researcher Heads $3.3 Million National Study in Rare Pediatric Diseases

University of Nebraska Medical Center researcher, William Rizzo, M.D., has received a five-year, $3.3 million grant to study 10 rare diseases that affect children beginning in infancy or early...

MRC Technology and Proximagen Collaborate to Develop Novel Therapeutics for Inflammatory and Autoimmune Disease

London, UK, 13 October 2014: MRC Technology, a leading technology transfer charity that helps bridge the gap between basic medical research and commercialisation in life sciences, helping early...

Tetraphase Pharmaceuticals Announces Presentation of Data at IDWEEK on the Activity of Eravacycline Against Multidrug-Resistant Bacteria

WATERTOWN, Mass.--()--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) announced today that researchers will present a poster at IDWeek 2014 showing the preclinical activity of...

Merck Serono to Collaborate with The Institute of Cancer Research, London, and Wellcome Trust to Co-Develop Anti-Cancer Drugs

Darmstadt, Germany, October 07, 2014 – Merck Serono, the biopharmaceutical division of Merck, The Institute of Cancer Research (ICR), and the Wellcome Trust, London, today announced a...

Policies of NIH, other funders, have improved data-sharing by life-science investigators

Policies of NIH, other funders, have improved data-sharing by life-science investigators While compliance with policies is common, areas of concern still 26/Sep/2014 Policies put into place by major...

September 29, 2014 - Mymetics' promising HIV vaccine candidate obtains funding to begin study at Texas Biomedical Research Institute

Epalinges, Switzerland, 29 September 2014 – Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious...

Hemispherx Biopharma Expands Research on Potential Ebola Treatments to Five Independent Experts/Institutional Collaborators

PHILADELPHIA - September 29, 2014 - Hemispherx Biopharma, Inc. (NYSE MKT: HEB) (the "Company" or "Hemispherx"), announced today a widened set of research collaborations designed...

Hemispherx Announces Primate Research Showing Alferon® LDO Protection from Pulmonary Damage Associated with Infection by Highly Pathogenic Influenza Virus

PHILADELPHIA - September 22, 2014 - Hemispherx Biopharma, Inc. (NYSE MKT: HEB) (the "Company" or "Hemispherx"), announced today a peer-reviewed publication entitled...

Scientists discover an on/off switch for aging cells

LA JOLLA–Scientists at the Salk Institute have discovered an on-and-off "switch" in cells that may hold the key to healthy aging. This switch points to a way to encourage healthy...

Pathway that contributes to Alzheimer's disease revealed by research

JACKSONVILLE, Fla. — Researchers at Jacksonville's campus of Mayo Clinic have discovered a defect in a key cell-signaling pathway they say contributes to both overproduction of toxic...

Japanese Global Health Fund Awards $33.5 Million in Grant Investments in Less Than a Year to Develop Vaccines and Drugs for Neglected Diseases

TOKYO, JAPAN (September 16, 2014)—The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight...

NYU Langone Scientists Report Reliable and Highly Efficient Method for Making Stem Cells

NEW YORK, September 18, 2014 – Scientists at NYU Langone Medical Center have found a way to boost dramatically the efficiency of the process for turning adult cells into so-called pluripotent...

UT Southwestern Researchers Discover Novel Class of NAMPT Activators for Neurodegenerative Disease

Newswise — DALLAS, Texas, and South San Francisco, Calif., Sept. 11, 2014 – UT Southwestern Medical Center, 2M Companies, and Calico today announce a new collaboration to advance research...

Protein appears to protect against bone loss in arthritis

AUGUSTA, Ga. – A small protein named GILZ appears to protect against the bone loss that often accompanies arthritis and its treatment, researchers report. Arthritis as well as aging prompt the...

BioFactura and Collaborators to Develop an Ebola Drug Under NIH Partnerships Grant

BioFactura, Inc. is a collaborator on a grant awarded to the Geneva Foundation. Ebola drug development funding will be provided under a Partnerships for Biodefense grant from the National Institutes...

NIH awards aim to improve understanding of cell pathways, development of new therapies

Building on a successful three-year pilot project, the National Institutes of Health has awarded more than $64 million to six research institutions to create a database of human cellular responses,...

Scientists revert human stem cells to pristine state

Rsearchers at EMBL-EBI have resolved a long-standing challenge in stem cell biology by successfully 'resetting' human pluripotent stem cells to a fully pristine state, at point of their...

NEW COMPOUND INHIBITS ENZYME CRUCIAL TO MERS/SARS VIRUSES, WITH A CATCH

WASHINGTON, DC – September 8, 2014 – Scientists at the University of Illinois, Chicago, have identified a compound that effectively inhibits an enzyme crucial to the viruses that cause...

Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC

ROCKVILLE, Md., Sept. 7, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific...

SUMMIT PRESENTS NEW POSITIVE PRECLINICAL EFFICACY DATA ON ITS SELECTIVE C DIFFICILE ANTIBIOTIC SMT19969 AT ICAAC 2014

Oxford, UK, 8 September 2014 – Summit (AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne Muscular Dystrophy and C. difficile infection ('CDI'),...